ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.

Zinc finger protein 139(ZNF139), a member of zinc finger protein family, is a transcription factor. Our previous research showed ZNF139 was overexpressed in gastric cancer cells. The purpose of present study is to explore impact and mechanism of ZNF139 on metastasis by regulating invasive ability of gastric cancer cells. Quantitative RT-PCR(QRT-PCR) and Western blot were applied for detection of ZNF139 expression in gastric cancer tissues, adjacent cancer tissues, metastatic lymph nodes, gastric cancer cell lines SGC7901 and BGC823 and gastric epithelial cell line GES-1; siRNA specific to ZNF139 was synthesized and then transfected into gastric cancer cell line BGC823; wound healing assay and Transwell assay were used to observe impact of ZNF139-siRNA after being transfected into BGC823 on its invasion and migration; changes in expression of invasion and migration-related genes MMP-2, MMP-9, ICAM-1 and TIMP1 were detected before and after transfection. Gelatin zymogrphy assay were applied to determine the MMP activities. Statistical analysis was based on the SPSS11.5 software.Expression of ZNF139 in gastric adenocarcinoma tissues and cells was significantly higher than the expression in the adjacent cancer tissues, but lower than the expression in the metastatic lymph nodes; ZNF139 expression was present in gastric cancer cell lines, and the expression level was higher than that in normal gastric epithelial cells lines. ZNF139-siRNA significantly inhibited the invasion and migration activity of gastric cancer cell line BGC823. 48h after ZNF139-siRNA was transfected into gastric cancer cell line BGC823, expression and activity of invasion-related genes MMP-2, MMP-9, ICAM-1 mRNA and protein were significantly inhibited, while expressions of TIMP-1 mRNA and protein were significantly increased. At the same time, the gelatinase activities of MMP2 and MMP9 were decreased by ZNF139 interference.ZNF139 was overexpressed in gastric cancer cells, and the expression was further enhanced in the metastasis process. Knocking down ZNF139 expression in gastric cancer cells could effectively reduce gastric cancer cell invasion and migration ability, and this process might play a role by regulating MMP-TIMP balance.

[1]  Ping Chen,et al.  Protein inhibitor of activated STAT-1 is downregulated in gastric cancer tissue and involved in cell metastasis. , 2012, Oncology reports.

[2]  Kui-cheng Zheng,et al.  Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer. , 2012, The Tohoku journal of experimental medicine.

[3]  M. Choi,et al.  Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer , 2012, The British journal of surgery.

[4]  Xiao-Feng Sun,et al.  PINCH Expression and Its Clinicopathological Significance in Gastric Adenocarcinoma , 2012, Disease markers.

[5]  Gwang Ha Kim,et al.  Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. , 2012, Histology and histopathology.

[6]  Shi-yao Chen,et al.  A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. , 2012, Gastrointestinal endoscopy.

[7]  Z. Miao,et al.  βig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis. , 2012, Molecular medicine reports.

[8]  Y. Mok,et al.  Expression of Intercellular Adhesion Molecule-1 and E-Selectin in Gastric Cancer and Their Clinical Significance , 2012, Journal of gastric cancer.

[9]  Shu-Ching Hsieh,et al.  Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells. , 2012, Biochemical and biophysical research communications.

[10]  J. Luk,et al.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. , 2012, World journal of gastroenterology.

[11]  H. Katagiri,et al.  Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma. , 2012, Anticancer research.

[12]  Zhen Wang,et al.  Function of chloride intracellular channel 1 in gastric cancer cells. , 2012, World journal of gastroenterology.

[13]  J. K. Kundu,et al.  Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β-catenin signaling , 2012, International journal of oncology.

[14]  Zhou Zhou,et al.  Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo , 2012, Oncology reports.

[15]  S. Itoh,et al.  Monocyte differentiation induced by co-culture with tumor cells involves RGD-dependent cell adhesion to extracellular matrix. , 2012, Cancer letters.

[16]  Shui Wang,et al.  Surgical outcomes for gastric cancer of a single institute in southeast China. , 2012, American journal of surgery.

[17]  Chengzhong Xing,et al.  Long-term survival results and prognostic factors of early gastric cancer. , 2011, Experimental and therapeutic medicine.

[18]  B. Mroczko,et al.  Gastric cancer - The role of matrix metalloproteinases in tumor progression. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[19]  Wei Liu,et al.  Impact of Lymphatic Vessel Invasion on Survival in Curative Resected Gastric Cancer , 2011, Journal of Gastrointestinal Surgery.

[20]  Yingwei Xue,et al.  Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma , 2011, Journal of surgical oncology.

[21]  S. Osinsky,et al.  Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[22]  W. Hop,et al.  Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction. , 2009, Cancer genetics and cytogenetics.

[23]  T. Motyl,et al.  Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[24]  Jun Zhou,et al.  Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line. , 2008, International journal of oncology.

[25]  D. Erdmann,et al.  Modulation of drug resistance by artificial transcription factors , 2008, Molecular Cancer Therapeutics.

[26]  Dazhi Sun,et al.  Syndrome differentiation in traditional Chinese medicine and E-cadherin/ICAM-1 gene protein expression in gastric carcinoma. , 2007, World journal of gastroenterology.

[27]  N. Tommerup,et al.  Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. , 1995, Genomics.

[28]  Zhou Zhou,et al.  Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. , 2012, Oncology reports.

[29]  Ping-li,et al.  Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach , 2012 .

[30]  G. Poptodorov,et al.  [The role of matrixmetalloproteinases in the tumor growth and metastasis]. , 2010, Khirurgiia.